[144] Core Molding Technologies, Inc. SEC Filing

Rhea-AI Filing Summary

Core Molding Technologies (CMT) filed a Form 144 disclosing a proposed sale of 10,000 common shares through ATB Capital Markets on 08/25/2025 with an aggregate market value of $194,700. The shares represent approximately 0.11% of the issuer's outstanding common stock of 8,857,907 shares. All 10,000 shares were acquired on 05/12/2023 as director stock grants from Thomas R. Cellitti and are identified as compensation. The filer reports no securities sold in the past three months. By signing, the seller represents no undisclosed material adverse information regarding the issuer.

Positive

• Full disclosure and compliance with Rule 144 filing requirements and use of a broker
• Sale originates from director stock grants received as compensation on 05/12/2023, not from an undisclosed secondary transfer
• No securities sold in the past three months by the person for whose account the securities are to be sold, reducing immediate pattern concerns
• Small size relative to outstanding shares (10,000 vs 8,857,907 ≈ 0.11%), indicating limited market impact

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale of previously granted director shares; immaterial size relative to total outstanding stock.

The Form 144 reports a director intends to sell 10,000 shares acquired as compensation in May 2023. The sale amount, $194,700, is small relative to the company’s total outstanding shares (about 0.11%), suggesting limited dilution or market impact. The use of a broker and formal filing indicates compliance with Rule 144 resale procedures. There are no reported prior sales in the past three months, reducing immediate pattern concerns. This disclosure provides transparency but does not, by itself, change the company’s financial picture.

Corporate Governance Expert

TL;DR: Insider sale is disclosed properly and originates from director compensation; governance controls appear followed.

The filing shows the shares were received as director stock grants and the director is following Rule 144 resale requirements by filing Form 144 and using a broker. The representation regarding lack of undisclosed material information is standard. Because the shares are from a compensation grant, the sale likely reflects personal liquidity rather than an indicator of adverse corporate developments. No signs in this filing of irregular governance actions or material noncompliance are evident.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	ATB Capital Markets USA Inc. #410, 585 8th Avenue SW Calgary Z4 T2P1G1	10000	194700.00	8857907	08/25/2025	NYSE American

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	05/12/2023	Stock Grant To Director	Thomas R. Cellitti			7711	05/12/2023	Compensation
Common Stock	05/12/2023	Stock Grant to Director	Thomas R. Cellitti			2289	05/12/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Core Molding Technologies' Form 144 disclose for CMT?

The Form 144 discloses a proposed sale of 10,000 common shares via ATB Capital Markets on 08/25/2025 with an aggregate market value of $194,700.

Who is selling the shares reported in the CMT Form 144?

The shares were acquired by director Thomas R. Cellitti as stock grants on 05/12/2023 and are being sold from that grant.

How material is the 10,000-share sale relative to CMT's outstanding stock?

The sale represents about 0.11% of outstanding common shares (10,000 of 8,857,907), so it is small in absolute terms.

Does the filing show any other securities sales by the seller in the past three months?

No. The Form 144 indicates "Nothing to Report" for securities sold during the past three months.

What is the acquisition nature and payment for the securities being sold?

The shares were acquired as stock grants to a director on 05/12/2023 and the payment nature is listed as compensation.